Angie Marlene Castle, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 205 Palmer Ave, Bellefontaine, OH 43311 Phone: 937-592-4015 |
Sophia Do Vang, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1860 S Main Street, Bellefontaine, OH 43311 Phone: 937-592-0727 |
Michelle Marie Grider, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2200 Timber Trl, Bellefontaine, OH 43311 Phone: 937-595-0100 |
Tracy Lynn Detwiler, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 212 E Columbus Ave Ste 1, Bellefontaine, OH 43311 Phone: 937-599-1411 Fax: 937-599-4128 |
Zoe Louise Henderson, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 212 E Columbus Ave Ste 1, Bellefontaine, OH 43311 Phone: 937-599-4128 |
Neil Mast, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1134 N Main St Ste 3100, Bellefontaine, OH 43311 Phone: 937-592-9799 |
James L Robinson, PA-C Physician Assistant - Surgical Medicare: Accepting Medicare Assignments Practice Location: 2221 Timber Trl, Bellefontaine, OH 43311 Phone: 937-599-1280 Fax: 937-599-1730 |
Chelsea Mangia Freels, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1850 S Main St, Bellefontaine, OH 43311 Phone: 740-405-8034 |
News Archive
Patients with active psoriatic arthritis receiving the interleukin (IL)-12/23 inhibitor STELARA (ustekinumab) experienced significant improvements in signs and symptoms of the disease, according to new findings presented today from a Janssen Research & Development, LLC, (Janssen)-sponsored investigational study.
A recently-recognized pathologic protein in the brain may play a larger role in the development of clinical Alzheimer's disease dementia than previously recognized, according to a study by researchers at Rush University Medical Center.
Researchers from UC San Diego, the University of California Los Angeles and Indiana University report having found, for the first time, that atrial fibrillation or irregular heart rhythms is caused by small electrical sources within the heart, in the form of electrical spinning tops ("rotors") or focal beats. Importantly, they found a way of detecting these key sources, then precisely targeting them for therapy that can shut them down in minutes with long lasting results.
Treating a liver disease called NASH (non-alcoholic steatohepatitis), which affects 10 to 15 percent of obese individuals with type-2 diabetes worldwide, is difficult. But now scientists believe they have found a pharmacologic approach that may inhibit NASH, and thus stop deadly conditions that result from NASH such as cirrhosis and liver cancer.
› Verified 8 days ago